UAE’s Stone Venture Leads Major Funding Round for Chinese Robotics Company

UAE investment firm Stone Venture has led a Series B funding round for Chinese robotics and embodied AI company GENISOM AI, securing “several hundred million yuan” in fresh capital, the company announced on September 20, 2026. The round included participation from Chinese financial and industrial investors such as Neusoft, Highpower Technology and Riying Electronics, though GENISOM AI did not disclose the exact amount or its post-money valuation.

"Gravity"

The transaction underscores Stone Venture’s role as the lead backer at a moment when GENISOM AI is scaling both R&D and manufacturing. The company is developing technologies across embodied AI — combining perception, movement, navigation and task execution — and has highlighted its GSD autonomous navigation system and internally developed CHAMP robotic joint modules as core components of its platform. GENISOM AI’s product range includes quadruped and humanoid robots built for industrial inspection, emergency response and other operational environments.

Context and operational details

• Production scale: GENISOM AI reported it had cumulatively produced more than 15,000 embodied AI robots by June 2026.
• Manufacturing capacity: The company stated its annual production capacity for CHAMP robotic joint modules exceeds 1 million units.
• Investor mix: Alongside Stone Venture, the Series B attracted Neusoft, Highpower Technology and Riying Electronics among other Chinese financial and industrial investors.
• Technology focus: GENISOM AI is building integrated systems to enable robots to perceive surroundings, make decisions and execute tasks with higher autonomy, moving beyond predefined movement routines.
• Gravity programme: The company plans a "Gravity" initiative that in its first phase will provide 1,000 robots and more than 100 million yuan in combined resources to developers, universities and industrial partners.

GENISOM AI and its new backers frame the funding as a bridge from advanced engineering to broader commercial deployment. The company is explicit that it seeks to convert production scale into operational projects and long-term commercial contracts, targeting international markets such as oil and gas, energy, security and emergency-response sectors where robots can operate in hazardous or hard-to-reach environments.

Analysts and company commentary in the announcement stress that production volume and manufacturing capacity are not synonymous with sales or deployment. The firm’s scale — more than 15,000 robots produced and a million-plus joint-module capacity — signals manufacturing maturity, but the critical next steps are securing customer contracts and demonstrable deployments outside China.

Outlook

• Regional expansion: Stone Venture’s leadership in the round gives GENISOM AI a potential pathway to Middle Eastern networks and industrial partners, though no specific customer contracts or purchase orders in the region were disclosed.
• Commercial tests ahead: The company must translate its manufacturing and technical capabilities into sustained commercial demand, proving use cases in the sectors it targets.
• Ecosystem play: The "Gravity" programme is intended to spur application development and testing by providing hardware and financial resources to developers, universities and industry partners — a strategic move to broaden real-world use cases.

The Series B is positioned less as an endpoint and more as a financing milestone that enables GENISOM AI to expand production, deepen its embodied AI stack and pursue international industrial contracts, with the coming quarters set to reveal whether that strategy converts capacity into commercial traction.